Medications like GLP-1s for perimenopause directly target menopause-related metabolic changes
Moreno YF, Sgarbieri VC, da Silva MN, Toro AA, Vilela MM (febrero de 2006)
These peptides are not technically illegal at the time of writing this article however the FDA has announced they may start coming after any compounding pharmacies found to be compounding these substances and therefore most human drug compounding pharmacies have begun clearing their shelves of peptides
10 Most importantly, they used an FDA warning letter as a weapon
Rather than focusing on one fixed price, patients should think about GLP-1 therapy as an investment in their long-term health
Treatment is $189/mo month-to-monthnth flat, HSA/FSA eligible, making it accessible regardless of insurance status